Other languages Cara Therapeutics, Inc.

Equities

CARA

US1407551092

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.6843 ^USD	-2.24%		+3.52%	-7.90%

Mar. 22	Cara Therapeutics, Inc. Announces Resignation of Dr. Joana Goncalves as Chief Medical Officer, Effective April 16, 2024	CI
Mar. 06	Canaccord Genuity Adjusts Cara Therapeutics Price Target to $10 From $11, Maintains Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cara Therapeutics, Inc. Announces Resignation of Dr. Joana Goncalves as Chief Medical Officer, Effective April 16, 2024	Mar. 22
Cara Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 04
Cara Therapeutics to Cut Workforce Up to 50%, Halt Work on Chronic Kidney Disease; Chief Scientific Officer to Exit	Jan. 22
Cara Therapeutics, Inc. Prioritizes Late-Stage Notalgia Paresthetica Program	Jan. 22
Cara Therapeutics, Inc. Announces Frédérique Menzaghi Departs as Chief Scientific Officer and SVP of Research & Development, Effective February 2, 2024	Jan. 22
Top Midday Decliners	Dec. 18
Cara Therapeutics, Inc. Announces Outcome from Dose- Finding Part A of the KIND 1 Study Evaluating Oral Difelikefalin for Mod Moderate-To-Severe Pruritus in Patients with Atopic Dermatitis	Dec. 18
Cara Therapeutics Q3 Loss Widens, Revenue Drops	Nov. 13
Cara Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Cara Therapeutics Says Partner Receives Approval of Korsuva Injection to Treat Pruritus in Hemodialysis Patients in Japan	23-09-25
Cara Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07
Cara Therapeutics, Inc. Appoints Helen M. Boudreau as Member of Board and Audit Committee	23-08-03
Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics, Inc. Announces England’s National Institute for Health and Care Excellence has Recommended Kapruvia	23-05-18
Cara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Sector Update: Health Care Stocks Decline with Broader Markets	23-03-07
Sector Update: Health Care Stocks Stumbling in Recent Trading	23-03-07
Top Midday Decliners	23-03-07
Sector Update: Health Care	23-03-07
Sector Update: Health Care Stocks Advance Pre-Bell Tuesday	23-03-07
Sector Update: Health Care	23-03-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cara Therapeutics, Inc.

Equities

CARA

US1407551092

Other languages

Filters